What is the optimal prognostic tool for the assessment of patients with newly diagnosed follicular lymphoma?

Leuk Lymphoma. 2007 Mar;48(3):452-3. doi: 10.1080/10428190701237911.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Humans
  • Lymphoma, Follicular / diagnosis*
  • Lymphoma, Follicular / therapy
  • Prognosis
  • Stem Cell Transplantation

Substances

  • Antineoplastic Agents